Friday, 29 March 2024
Aerie Pharmaceuticals Inc.
No Risk Alert Here: Before we dive into any analysis we simply note that Aerie Pharmaceuticals Inc (NASDAQ:AERI) risk is neither elevated nor depressed.
more»
05:07 | 14/3/18
Market Exclusive
On or after March 13, 2018, representatives of Aerie Pharmaceuticals, Inc. (the “Company”) may present to various investors the information described in the slides attached to this report as Exhibit 99.1 hereto, which is hereby incorporated by ...
more»
11:30 | 10/3/18
Simply Wall St
Mid-caps stocks, like Aerie Pharmaceuticals Inc (NASDAQ:AERI) with a market capitalization of US$2.25B, aren't the focus of most investors who prefer to direct their investments towards either large-cap or small-cap stocks.
more»
04:11 | 9/3/18
Post Analyst
Shares of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) opened at $55.05, and ended 3.08% higher at $56.9. Nearly 0.28 million shares were traded by the close, lower than its average daily volume of 0.38 million shares.
more»
03:15 | 9/3/18
First News 24
Global Proliferative Diabetic Retinopathy Therapeutics market analyzes the current and future prospects of the Proliferative Diabetic Retinopathy Therapeutics market worldwide.
more»
10:45 | 8/3/18
Frisco Fastball
Macquarie Grp Incorporated Ltd holds 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) or 30,760 shares. Rice Hall James & Associate Ltd Company invested 0.51% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Vanguard Gru Inc reported 3.00M shares. Ghost ...
more»
02:30 | 8/3/18
The Lincolnian Online
Aerie Pharmaceuticals logo Aerie Pharmaceuticals (NASDAQ:AERI)'s stock had its “buy” rating reissued by equities researchers at Seaport Global Securities in a research report issued to clients and investors on Monday.
more»
01:22 | 8/3/18
Digital Journal
DURHAM, N.C.--(Business Wire)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle ...
more»
This is a slightly advanced option trade that starts two calendar days after Aerie Pharmaceuticals Inc (NASDAQ:AERI) earnings and lasts for the 19 calendar days to follow, that has been a winner for the last 2 years.
more»
07:00 | 6/3/18
Street Observer
Aerie Pharmaceuticals, Inc. (AERI) stock price moved with surging change along with the volume 0.6 million shares in Friday trading session.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |